Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05310409 · ClinicalTrials.gov registry record
PAN-PROMISE to Detect Post-ERCP Pancreatitis Symptoms
A clinical trial of Post-ERCP Acute Pancreatitis, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 700
- Enrollment target
- 2
- Study locations
NCT05310409 is a study of Post-ERCP Acute Pancreatitis that has completed, run by University of Pennsylvania. The registered enrollment target is 700 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT05310409, a study of Post-ERCP Acute Pancreatitis, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 700 participants
- Enrollment target
- 2
- Study locations
Study Summary
The aim of this study is to use a validated patient-reported outcome measure to evaluate how many patients have symptoms of pancreatitis after ERCP and how it correlates with their quality of life and productivity.
Conditions Studied
Study Locations (2)
California
- University of California, San Francisco - San Francisco
Pennsylvania
- University of Pennsylvania Health System - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2020-09-15 |
| Est. Completion | 2023-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05310409
The ClinicalTrials.gov registry entry for NCT05310409 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post-ERCP Acute Pancreatitis appearing as the primary indexed condition, and to 0 interventions.
NCT05310409 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05310409 about?
NCT05310409 is a clinical study titled "PAN-PROMISE to Detect Post-ERCP Pancreatitis Symptoms". The aim of this study is to use a validated patient-reported outcome measure to evaluate how many patients have symptoms of pancreatitis after ERCP and how it correlates with their quality of life and productivity.
What is the current status of trial NCT05310409?
This trial is currently completed. The enrollment target is 700 participants. The study started on 2020-09-15. Estimated completion is 2023-01-01.
What conditions does trial NCT05310409 study?
This clinical trial studies the following conditions: Post-ERCP Acute Pancreatitis.
Who is sponsoring clinical trial NCT05310409?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05310409 being conducted?
This trial has 2 study locations across California, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post-ERCP Acute Pancreatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.